Takeda (TSE:4502/NYSE:TAK) today announced the U.S. availability of GAMMAGARD LIQUID™ ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, by prescription, ...

Travel foods, just like those eaten at home, have a strong effect on your microbiome and your health. A well-fed microbiome ...

This year is expected to be the busiest on record for holiday travel. This Christmas and New Year's holiday period is expected to be the busiest on record. More than 122 million people are expected to ...

Kimchi may do far more than add flavor to meals—it could help fine-tune the human immune system. A clinical study using advanced single-cell genetic analysis found that regular kimchi consumption ...

STRENGTHENING NATIONAL SECURITY THROUGH COMMON SENSE RESTRICTIONS BASED ON DATA: Today, President Donald J. Trump signed a Proclamation expanding and strengthening entry restrictions on nationals from ...

Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...

International tourists visiting popular national parks in the US next year will be required to pay additional fees and raised rates on annual passes, the US Department of the Interior announced ...

A record number -- over 81 million people -- are expected to travel this year. A record number of Americans are expected to travel for Thanksgiving this year, AAA said. AAA predicts 81.8 million ...

AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older. Approved by the U ...

The story of Russia’s invasion of Ukraine has been one of upset expectations and wild swings in performance. At the start of the war, most of NATO saw Russia as an unstoppable behemoth, poised to ...